Production (Stage)
CorMedix Inc.
CRMD
$11.22
-$0.49-4.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 242.71% | 191.26% | 71.50% | -25.53% | -36.90% |
| Total Depreciation and Amortization | 642.66% | 614.97% | 334.83% | 341.95% | 28.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.01% | 9.34% | 21.98% | 19.23% | 10.27% |
| Change in Net Operating Assets | 13.66% | -851.82% | -156,506.41% | -179.44% | -155.47% |
| Cash from Operations | 214.02% | 47.75% | -56.94% | -63.78% | -66.54% |
| Capital Expenditure | 83.36% | 96.65% | 3.92% | -443.75% | -314.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -102.05% | -132.93% | 1,198.01% | 364.92% | 161.38% |
| Cash from Investing | -102.18% | -150.89% | 1,177.08% | 362.75% | 160.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 2,324.18% | -67.19% | -78.44% | -- |
| Repurchase of Common Stock | -949.43% | -- | -- | 29.69% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,374.87% | 2,312.83% | -67.19% | -80.25% | -101.35% |
| Foreign Exchange rate Adjustments | 125.00% | -150.00% | 119.05% | -150.00% | -134.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 402.89% | 155.44% | -79.93% | -19.74% | 52.66% |